Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “molecular”

183 pharma patents match "molecular" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 183
Index total 30,257
Page 6 / 8

Quick answer

This filtered view shows 183 pharmaceutical patents matching "molecular" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

183 results for “molecular” · 30,257 patents in full index Clear search

  1. US 8772013

    Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted

  2. US 8735075

    Cancer screening by detection of ultrastructural and molecular markers

    Northwestern University · Granted May 27, 2014 · Expires May 22, 2034

    granted

  3. US 8735566

    Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted May 27, 2014 · Expires May 22, 2034

    granted

  4. US 8691963

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  5. US 8669101

    Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted

  6. US 8647818

    Molecular scaffolds for HIV-1 immunogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services (Hereinafter the Government) Office of Technology Transfer, National Institutes of Health · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  7. US 8632771

    High molecular weight derivatives of vitamin K-dependent polypeptides

    The United States of America as represented by Department of Veterens Affairs · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  8. US 8591862

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  9. US 8552067

    Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses therefor

    The Regents of the University of California · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted

  10. US 8545813

    Pre-templated macromolecular architectures with multiple Gd(III) complexes and methods of use as MRI contrast agents

    Northwestern University · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

  11. BR PI0714667

    conjugado molecular e respectivo uso

    CERAMOPTEC IND INC [US] · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  12. US 8481478

    Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry

    The Regents of the University of California · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  13. US 8449877

    Pharmaceutically purified intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted May 28, 2013 · Expires May 23, 2033

    granted

  14. US 8288530

    Method of preparing macromolecular contrast agents and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted

  15. US 8263657

    Inhibitors against the production and release of inflammatory cytokines

    Institute of Medicinal Molecular Design, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted

  16. US 8148343

    Tumor suppressor factor

    Molecular Discover Systems · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted

  17. US 8129335

    Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry

    The Regents of the University of California · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted

  18. US 8097759

    Inflammatory cytokine release inhibitor

    Institute of Medicinal Molecular Design, Inc. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted

  19. US 8097610

    Derivative having PPAR agonistic activity

    Institute of Medicinal Molecular Design, Inc. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted

  20. US 8076100

    Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  21. US 8044236

    Carboxilic acid derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  22. US 8003091

    Pharmaceutical compositions comprising purified intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  23. US 7998992

    Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1

    Institute of Medicinal Molecular Design, Inc. · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  24. US 7884234

    N-phenyloxamide derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.